Cerenome introduces CNSide CSF Molecular Profile tests
CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Cerenome), announced the commercial launch of two new cerebrospinal fluid (CSF)─based molecular profiling tests, available to health care
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →